Our vision is to find solutions to global infectious disease challenges. One of the biggest challenges facing the world today is antimicrobial resistance to drug treatments – and this, in its broadest context, is a major area of focus.
By taking a multi-disciplinary approach involving genomics, bacterial genetics, molecular microbiology, structural biology and mathematical modelling our aim is to tackle significant global health-care challenges such as tuberculosis, pneumonia, fungal pathogens, gastrointestinal infection, blood stream infections, and health-care associated infections.
Our faecal microbiota transplantation research explores another form of treatment where conventional antibiotics has failed. Housed within the Advanced Therapies Facility, our Microbiome Treatment Centre is leading the production of refined microbiota, by extracting and analysing the gut microbiome from carefully-screened donor stools prior to transplantation.